Access Biotechnology

About

Portfolio · 1

Altshuler Shaham

Altshuler Shaham is a leading Israeli investment house managing a wide range of financial products and services.

Led ★ 1 round $200.0M committed Latest: 2023-06

Investment activity

Q&A

What is Access Biotechnology's investment thesis?

Access Biotechnology invests in transformative therapies for conditions with high unmet needs that have the potential to meaningfully impact human health.

What is Access Biotechnology's primary sector focus?

Access Biotechnology primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated there.

Can you name a notable portfolio company for Access Biotechnology?

Upstream Bio, a company developing a monoclonal antibody drug for asthma patients, is a notable portfolio company for Access Biotechnology.

What was Access Biotechnology's most recent investment activity?

Access Biotechnology participated in a B Round investment in June 2023, according to startupim data.

What type of investor is Access Biotechnology?

Access Biotechnology is a corporate venture capital firm.

What is the typical investment range for Access Biotechnology?

Access Biotechnology's investment range is typically between $200M and $200M.

When did Access Biotechnology make its first recorded investment?

Access Biotechnology made its first recorded investment in an A Round in June 2022.